• Erlotinib 100mg

Erlotinib 100mg

SKU:52038

Erlotinib is used for non-small cell lung cancer that has spread and has an EGFR exon 19 deletion or exon 21 L858R mutation.

It is also used with gemcitabine for pancreatic cancer that is locally advanced, cannot be removed by surgery, or has spread.

Usual adult dose range: 100mg to 150mg once daily, depending on whether it is used for pancreatic cancer or lung cancer.


Indications vary by country and change over time; this website contains information for general patient information and should be checked against local prescribing information before clinical use.

Verification Approach: Each indication and usual dose-range sentence was drafted from at least two recognised medicines information sources, usually FDA/DailyMed or an FDA label plus EMA/eMC, MedlinePlus, Mayo Clinic, Cancer Research UK, NCI/ Cancer.gov, or another reputable medicines-information source. Doses are general adult/patient-information ranges and must not be used to prescribe or change treatment.


  • FDA/DailyMed prescribing information and FDA Oncology/Hematology approval notifications.
  • EMA and UK eMC Summary of Product
    Characteristics and patient leaflets where available.
  • NCI Cancer Drug Information/Cancer.gov and Cancer Research UK medicine information where available.
  • MedlinePlus, NHS/NICE, and other national medicines information for non-oncology or immune/respiratory medicines.
  • Peer-reviewed FDA approval summaries or manufacturer regulatory notices for very new, withdrawn, or region-specific
    indications.